ACTG Presents Data from Mpox Study STOMP at CROI
ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating that tecovirimat did not improve ...
The Manila Times6h
Senior Planet from AARP Celebrates Sixth Cohort of Older Adult "Sponsored Athletes" Who Inspire Through Health and Fitness
Shebah Carfagna, Age 67 (Miami, FL) - Inspired by personal challenges, Shebah views exercise as medicine. Following a hip ...
‘Why Is An Adult Marrying A Child?’: IU’s Dialogue Goes Viral Amid Kim Soo-Hyun Controversy, Netizens Agree
South Korean actor Kim Soo-hyun has been facing the wrath of the netizens for the past couple of days after late actress Kim ...
NASA's newest space telescope Spherex blasts off to map the entire sky and millions of galaxies
NASA's newest space telescope rocketed into orbit Tuesday to map the entire sky like never before—a sweeping look at hundreds ...
Scene Calendar: 'Sing Into Spring,' art in High Springs and Grammy winner Time for Three
The seasonal Art Walk events return to historic downtown High Springs from noon to 5 p.m. March 15 featuring 15 to 20 local ...
Independent Newspaper Nigeria on MSN13h
Young Adults From Nigeria, Kenya LeadIn Global Mental Well-Being — Report
The Mental State of the World 2024 Report has revealed that young adults from Nigeria and Kenya show stronger mental resilience compared to their high-income nations’ peers, where youth mental ...
Most AAPI adults don’t support cutting agencies and want a focus on costs, new poll shows
The results come as President Trump continues what his administration says are cost-cutting measures under the newly formed ...
RFK Jr. touts vitamin A and cod liver oil for measles. Here’s what the science says.
In response, Secretary of Health and Human Services Robert F. Kennedy Jr. has praised the benefits of the measles, mumps, and ...
The Manila Times23h
Zevra Reports Full Year 2024 and Fourth Quarter Financial Results
On Feb. 27, 2025, Zevra entered into an asset purchase agreement for the sale of a Rare Pediatric Disease Priority Review Voucher (PRV), issued by the U.S. FDA upon the approval of MIPLYFFA, for $150 ...